open access

Vol 80, No 8 (2009)
ARTICLES
Get Citation

The thymidine phosphorylase as the platelet-derived endothelial cell growth factor of endometrial cancer

Jacek Bartkowiak, Katarzyna Wójcik-Krowiranda, Monika Smolarek, Elżbieta Miszczak-Zaborska, Robert Kubiak
Ginekol Pol 2009;80(8).

open access

Vol 80, No 8 (2009)
ARTICLES

Abstract

Abstract Objectives: The aim of the study was to assess the correlation between the activity of thymidine phosphorylase (TP) and the platelet derived-endothelial cell growth factor (PD-ECGF) expression in endometrial carcinoma. Methods: The study group consisted of 40 tissue samples taken from patients with endometrial carcinoma, who underwent surgery in First Clinic of Gynecology and Oncologic Gynecology of Medical University in Lodz. The control tissue samples were taken from patients who were operated on for non-oncologic reason. The activity of TP was measured by the spectrophotometric method in the cytosol of tumor cells, and the immunohistochemical staining of PD-ECGF was performed in the same tumors. The results of TP activity were compared with the microvessel density (MD) assessed by immunohistochemical analysis and with clinico-pathological features like tumor grade and FIGO stage. Result: A positive correlation between the enzyme activity and expression of TP/PD-ECGF protein was found. Moreover, a significantly higher TP activity was confirmed in malignant tumors from endometrial cancer patients when compared to the controls. A positive correlation between the enzyme activity and MD was also stated, but there was no connection to the grade of tumors and FIGO stage. Since the TP activity proved to be related to PD-ECGF expression and angiogenesis, we can state that TP seems to be an active form of PD-ECGF growth factor in endometrial carcinoma. This is in agreement with the results of many publications on other malignancies. The proper modulation of this activity may be useful in adjuvant therapies.

Abstract

Abstract Objectives: The aim of the study was to assess the correlation between the activity of thymidine phosphorylase (TP) and the platelet derived-endothelial cell growth factor (PD-ECGF) expression in endometrial carcinoma. Methods: The study group consisted of 40 tissue samples taken from patients with endometrial carcinoma, who underwent surgery in First Clinic of Gynecology and Oncologic Gynecology of Medical University in Lodz. The control tissue samples were taken from patients who were operated on for non-oncologic reason. The activity of TP was measured by the spectrophotometric method in the cytosol of tumor cells, and the immunohistochemical staining of PD-ECGF was performed in the same tumors. The results of TP activity were compared with the microvessel density (MD) assessed by immunohistochemical analysis and with clinico-pathological features like tumor grade and FIGO stage. Result: A positive correlation between the enzyme activity and expression of TP/PD-ECGF protein was found. Moreover, a significantly higher TP activity was confirmed in malignant tumors from endometrial cancer patients when compared to the controls. A positive correlation between the enzyme activity and MD was also stated, but there was no connection to the grade of tumors and FIGO stage. Since the TP activity proved to be related to PD-ECGF expression and angiogenesis, we can state that TP seems to be an active form of PD-ECGF growth factor in endometrial carcinoma. This is in agreement with the results of many publications on other malignancies. The proper modulation of this activity may be useful in adjuvant therapies.
Get Citation

Keywords

Thymidine phosphorylase, platelet derived-endothelial cell growth factor, Endometrial Neoplasms

About this article
Title

The thymidine phosphorylase as the platelet-derived endothelial cell growth factor of endometrial cancer

Journal

Ginekologia Polska

Issue

Vol 80, No 8 (2009)

Bibliographic record

Ginekol Pol 2009;80(8).

Keywords

Thymidine phosphorylase
platelet derived-endothelial cell growth factor
Endometrial Neoplasms

Authors

Jacek Bartkowiak
Katarzyna Wójcik-Krowiranda
Monika Smolarek
Elżbieta Miszczak-Zaborska
Robert Kubiak

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl